The global epigenetics diagnostic market size is expected to reach USD 39.15 billion by 2030, expanding at a CAGR of 15.10% over the forecast period, according to a new study by Grand View Research, Inc. The growth is attributed to the rising incidence of major depressive disorder (MDD). According to WHO, in 2023, around 5% of adults suffer from depressive disorder. Furthermore,...